← Open Payments lookup

HELEN SOLIMAN: Open Payments

NPI 1245798404 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$985 in 43 payments from 18 companies in 2025. Trend: 2023 $1,076 · 2024 $1,568 · 2025 $985

Food & beverage: $985
CompanyPaymentsAmount
ABBVIE INC.14$310
UCB, Inc.4$111
Biogen, Inc.3$88
EMD Serono, Inc.3$72
Lilly USA, LLC3$61
Neurocrine BioSciences, Inc.2$57
Novartis Pharmaceuticals Corporation2$35
Amgen Inc.2$34
TG Therapeutics, Inc.1$31
SK Life Science, Inc.1$28

Products named: QULIPTA, BOTOX, Briviact, KISUNLA, AVONEX, INGREZZA, KESIMPTA, UPLIZNA.

Industry payments across IN — which companies pay providers there.